$UNH bullish thoughts, no deep thinking, welcome to discuss. With almost all LLMs launching their own medical models, the implementation of large models in the healthcare industry is a given, but the empowerment of traditional healthcare companies is not so clear. UNH's existing advantages: data, doctor teams, drug delivery. From a broad perspective, I believe large models should be able to empower them, it's hard to quantify the impact on EPS, but the direction should be correct, what do you think?